Szeman Ruby Chan
Impact in
- Oncology top 10%
- Viral-associated cancers and disorders
- Cytokine Signaling Pathways and Interactions
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Oncology 8
- Cytokine Signaling Pathways and Interactions 5
- Viral-associated cancers and disorders 3
-
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 2
- Co-authors
- Bala Chandran (3 shared papers)Clark Bloomer (2 shared papers)Robert D. Schreiber (6 shared papers)Amy M. Fowler (4 shared papers)Michael M. Quigley (1 shared paper)Alexis K. Smith (1 shared paper)Raluca I. Verona (1 shared paper)Karla R. Wiehagen (1 shared paper)
- Journals
- Journal of Nuclear Medicine (2 papers)Virology (2 papers)Cell Death and Differentiation (1 paper)Oncotarget (1 paper)Scientific Reports (1 paper)
- Partner nations
- United StatesItalyIreland
In The Last Decade
Szeman Ruby Chan
15 papers receiving 794 citations
Peers
Comparison fields: 5 of 60
- Oncology 485
- Immunology 255
- Cancer Research 92
- Epidemiology 199
- Genetics 102
Countries citing papers authored by Szeman Ruby Chan
This map shows the geographic impact of Szeman Ruby Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Szeman Ruby Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Szeman Ruby Chan more than expected).
Fields of papers citing papers by Szeman Ruby Chan
This network shows the impact of papers produced by Szeman Ruby Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Szeman Ruby Chan. The network helps show where Szeman Ruby Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Szeman Ruby Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 152 | |
| 2 | 2012 | 151 | |
| 3 | 1998 | 92 | |
| 4 | 1998 | 78 | |
| 5 | 2012 | 61 | |
| 6 | 2013 | 55 | |
| 7 | 2000 | 51 | |
| 8 | 2019 | 40 | |
| 9 | 2013 | 38 | |
| 10 | 2014 | 33 | |
| 11 | 2016 | 22 | |
| 12 | 2016 | 8 | |
| 13 | 2015 | 7 | |
| 14 | 2017 | 7 | |
| 15 | 2022 | 6 |
About Szeman Ruby Chan
Szeman Ruby Chan is a scholar working on Oncology, Immunology, Genetics, Endocrinology, Diabetes and Metabolism and Epidemiology, having authored 15 papers that have together received 801 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (5 papers), Cytomegalovirus and herpesvirus research (3 papers), Estrogen and related hormone effects (3 papers), Herpesvirus Infections and Treatments (3 papers), Viral-associated cancers and disorders (3 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). The work is most often cited by research in Oncology (485 citations), Immunology (255 citations), Cancer Research (92 citations), Epidemiology (199 citations) and Genetics (102 citations). Szeman Ruby Chan has collaborated with scholars based in United States, Italy and Ireland. Frequent co-authors include Bala Chandran, Clark Bloomer, Robert D. Schreiber, Amy M. Fowler, Michael M. Quigley, Alexis K. Smith, Raluca I. Verona, Karla R. Wiehagen, Natasha M. Girgis and Iqbal S. Grewal. Their work appears in journals such as Journal of Nuclear Medicine, Virology, Cell Death and Differentiation, Oncotarget and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.